ISSN: 2048-9145

Pharmaceutical Bioprocessing

Scholarly Open Access Medicinal Plants Journals

Medicinal plants are the future of medicine. Phytomedicines are coming to equal prominence with orthodox medicines worldwide. However, some medicinal plants are becoming endangered species. It is interesting to note that many cardioprotective principles have been found in various plants, but these compounds are not going to clinical trials and then ultimately to pharmacy. The focus of phytotherapy research should be drug development from medicinal plants. Phytochemicals that modulate enzymes that are targets for therapy should be characterized. Identified cardioactive phytochemicals or derived simpler analogues should be synthesized to preserve species. The synergistic bioactivity of phytochemicals in plant extracts often is touted as a plus that's difficult to duplicate by single synthetic drugs. It is our suggestion that “hybrid phytochemicals” which will mimic this synergistic property might be synthesized using templates from plants. Despite advancements in the fight against cardiovascular diseases, it has remained the number one cause of mortality worldwide. Cardioprotective medicinal plants can greatly contribute to stemming the tide of this disease. However, because only a skinny line of demarcation exists between a medicinal plant being cardioprotective and its being a poison sometimes, proper classification and screening is important. This information should be available to all users of medicinal plants.    

High Impact List of Articles

Relevant Topics in Clinical